美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

基因编辑

318.69

+11.443.72%

涨家数：5

跌家数：1

平家数：- -

市盈率：- -

高：331.55

开：307.30

低：300.46

收：307.22

数据加载中...

蓝鸟生物盘中异动下午盘股价大跌5.07%

Editas Medicine, Inc.盘中异动大幅拉升5.47%

Beam Therapeutics Inc.盘中异动早盘快速拉升5.06%报17.86美元

Intellia Therapeutics, Inc.盘中异动大幅上涨5.26%报7.61美元

Intellia Therapeutics, Inc.盘中异动股价大涨5.03%报7.21美元

Crispr Therapeutics Ag盘中异动早盘股价大跌5.04%报36.99美元

Beam Therapeutics Inc.盘中异动快速下跌5.03%

Intellia Therapeutics, Inc.盘中异动早盘大幅下跌5.16%报6.98美元

Editas Medicine, Inc.盘中异动早盘大幅下挫5.18%

蓝鸟生物股价重挫10.07% 市值跌378.69万美元

BUZZ-青鸟生物因艾尔米德公司未能给出具有约束力的收购要约而下跌

蓝鸟生物盘中异动早盘股价大跌5.46%报4.50美元

Editas Medicine, Inc.盘中异动股价大涨5.21%

Editas Medicine, Inc.盘中异动大幅下挫5.23%报1.23美元

Sangamo Therapeutics, Inc.盘中异动股价大涨5.01%报0.755美元

蓝鸟生物盘中异动早盘股价大跌5.63%报4.86美元

Beam Therapeutics Inc.盘中异动快速拉升5.11%

蓝鸟生物盘中异动快速上涨5.78%报4.94美元

Editas Medicine, Inc.盘中异动股价大涨5.41%

Intellia Therapeutics, Inc.盘中异动急速拉升5.02%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4556/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4556","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"基因编辑","latestPrice":318.65814,"timestamp":1745263832025,"preClose":307.21762,"halted":0,"volume":13562090,"delay":0,"changeRate":0.037239,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":11.440521,"latestTime":"04-21 15:30:33 EDT","open":307.2963,"high":331.54907,"low":300.45554,"amount":132314952.256707,"amplitude":0.10121,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1745265600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":1.601709,"peRate":-3.192578,"turnoverRate":0.024034,"increases":5,"decrements":1,"flats":0,"marketCap":6183181404,"floatMarketCap":5615160304},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","high":331.54907,"amplitude":0.10121,"preClose":307.21762,"low":300.45554,"pbRate":"1.601709","latestPrice":318.68646,"volume":13565512,"delay":0,"open":307.2963,"prevYearClose":376.62552,"prevWeekClose":307.2176,"prevMonthClose":297.7814,"prevQuarterClose":297.7814,"fiveDayClose":309.6937,"twentyDayClose":360.9173,"sixtyDayClose":405.8632,"secType":"PLATE","market":"US","turnoverRate":0.024041,"peRate":-3.192578,"marketCap":6181267356,"floatMarketCap":5613905776,"timestamp":1745263836022,"nameCN":"基因编辑"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4556\",,,,undefined,":{"bkCode":"BK4556","up":5,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4556\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529319663","title":"蓝鸟生物盘中异动 下午盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529319663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529319663?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 01:46","pubTimestamp":1745257575,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日01时46分，蓝鸟生物股票出现异动，股价快速跳水5.07%。截至发稿，该股报3.93美元/股，成交量3.4246万股，换手率0.35%，振幅4.38%。机构评级方面，在所有5家参与评级的机构中，20%的券商给予买入建议，80%的券商给予持有建议，无券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中，整体跌幅为0.66%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422014615a4615edd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422014615a4615edd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4578","BK4139","BLUE"],"gpt_icon":0},{"id":"2529389678","title":"Editas Medicine, Inc.盘中异动 大幅拉升5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529389678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529389678?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 22:13","pubTimestamp":1745244825,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时13分，Editas Medicine, Inc.股票出现异动，股价急速上涨5.47%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421221345aa2c7440&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421221345aa2c7440&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4556","BK4139"],"gpt_icon":0},{"id":"2529002118","title":"Beam Therapeutics Inc.盘中异动 早盘快速拉升5.06%报17.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529002118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529002118?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 22:09","pubTimestamp":1745244551,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时09分，Beam Therapeutics Inc.股票出现波动，股价快速拉升5.06%。截至发稿，该股报17.86美元/股，成交量19.0309万股，换手率0.19%，振幅6.61%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220911aa2c7438&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220911aa2c7438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4556","BK4611","BK4139","BK4588","BK4585","LENZ","BEAM","BK4505","BK4535"],"gpt_icon":0},{"id":"2529802975","title":"Intellia Therapeutics, Inc.盘中异动 大幅上涨5.26%报7.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529802975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529802975?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 21:43","pubTimestamp":1745243018,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时43分，Intellia Therapeutics, Inc.股票出现异动，股价快速上涨5.26%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421214339973f752c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421214339973f752c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4556","LU1861558580.USD","LENZ","BK4139","BK4588","BK4585","NTLA","LU1861559042.SGD","BK4535"],"gpt_icon":0},{"id":"2528778867","title":"Intellia Therapeutics, Inc.盘中异动 股价大涨5.03%报7.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528778867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528778867?lang=zh_cn&edition=fundamental","pubTime":"2025-04-18 03:36","pubTimestamp":1744918600,"startTime":"0","endTime":"0","summary":"北京时间2025年04月18日03时36分，Intellia Therapeutics, Inc.股票出现波动，股价大幅上涨5.03%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418033641aa2c739c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418033641aa2c739c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","BK4535","NTLA","LU1861559042.SGD","BK4556","BK4585","BK4588","LU1861558580.USD"],"gpt_icon":0},{"id":"2527424952","title":"Crispr Therapeutics Ag盘中异动 早盘股价大跌5.04%报36.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527424952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527424952?lang=zh_cn&edition=fundamental","pubTime":"2025-04-16 22:03","pubTimestamp":1744812231,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日22时03分，Crispr Therapeutics Ag股票出现波动，股价大幅下跌5.04%。截至发稿，该股报36.99美元/股，成交量23.3247万股，换手率0.27%，振幅4.03%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为1.39%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416220351aa2c718c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416220351aa2c718c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4007","BK4588","BK4556","BK4611","LU1861558580.USD","LENZ","CRSP","LU1861559042.SGD"],"gpt_icon":0},{"id":"2527408246","title":"Beam Therapeutics Inc.盘中异动 快速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527408246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527408246?lang=zh_cn&edition=fundamental","pubTime":"2025-04-16 21:53","pubTimestamp":1744811592,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时53分，Beam Therapeutics Inc.股票出现异动，股价大幅下跌5.03%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.12%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041621531294d7885c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041621531294d7885c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4611","BK4007","BK4535","BK4139","BK4556","BK4505","BK4585","BEAM","LENZ","BK4588"],"gpt_icon":0},{"id":"2527958244","title":"Intellia Therapeutics, Inc.盘中异动 早盘大幅下跌5.16%报6.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527958244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527958244?lang=zh_cn&edition=fundamental","pubTime":"2025-04-16 21:53","pubTimestamp":1744811581,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时53分，Intellia Therapeutics, Inc.股票出现异动，股价快速跳水5.16%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.12%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416215302a45b3276&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416215302a45b3276&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4585","BK4007","BK4588","LU1861558580.USD","LU1861559042.SGD","BK4535","BK4556","NTLA","BK4139"],"gpt_icon":1},{"id":"2527439392","title":"Editas Medicine, Inc.盘中异动 早盘大幅下挫5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527439392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527439392?lang=zh_cn&edition=fundamental","pubTime":"2025-04-16 21:40","pubTimestamp":1744810832,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时40分，Editas Medicine, Inc.股票出现异动，股价急速跳水5.18%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp.涨幅较大，Briacell Therapeutics Corp.、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为399.65%、147.82%、43.72%，振幅较大的相关个股有天演药业、Psyence Biomedical Ltd C/Wts 25/01/2029、Phio Pharmaceuticals Corp.，振幅分别为20.62%、20.00%、18.52%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416214032aa2c7155&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416214032aa2c7155&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","EDIT"],"gpt_icon":0},{"id":"2527824483","title":"蓝鸟生物股价重挫10.07% 市值跌378.69万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527824483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527824483?lang=zh_cn&edition=fundamental","pubTime":"2025-04-16 21:30","pubTimestamp":1744810225,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时30分，蓝鸟生物股票出现波动，股价急速下跌10.07%。截至发稿，该股报4.02美元/股，成交量3.5849万股，换手率0.37%，振幅0.49%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Dermata Therapeutics Inc C/Wts 、天演药业、Essa Pharma Inc.涨幅较大，Briacell Therapeutics Corp.、Pmgc Holdings Inc.、Mural Oncology Plc较为活跃，换手率分别为325.01%、143.92%、8.06%，振幅较大的相关个股有天演药业、蓝鸟生物、Pasithea Therapeutics Corp.，振幅分别为20.00%、10.07%、4.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416213026a6bca2fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416213026a6bca2fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4578","BLUE","BK4139","ADAG"],"gpt_icon":0},{"id":"2527821212","title":"BUZZ-青鸟生物因艾尔米德公司未能给出具有约束力的收购要约而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2527821212","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527821212?lang=zh_cn&edition=fundamental","pubTime":"2025-04-16 20:54","pubTimestamp":1744808095,"startTime":"0","endTime":"0","summary":"** BLUE 补充说，该公司仍面临严重的贷款违约风险。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nL4S3QU0Z8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BLUE","BK4139","BK4578","CG","IE00BGHQF748.EUR","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4556"],"gpt_icon":0},{"id":"2527445204","title":"蓝鸟生物盘中异动 早盘股价大跌5.46%报4.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527445204","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527445204?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 22:31","pubTimestamp":1744727486,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日22时31分，蓝鸟生物股票出现波动，股价急速跳水5.46%。截至发稿，该股报4.50美元/股，成交量2.2084万股，换手率0.23%，振幅3.99%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Mural Oncology Plc、Psyence Biomedical Ltd C/Wts 25/01/2029、Skye Bioscience, Inc.涨幅较大，Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为827.43%、230.25%、94.02%，振幅较大的相关个股有Skye Bioscience, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Mural Oncology Plc，振幅分别为171.53%、80.08%、66.02%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504152231269738b5a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504152231269738b5a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BLUE","BK4578","BK4139"],"gpt_icon":0},{"id":"2527767412","title":"Editas Medicine, Inc.盘中异动 股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527767412","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527767412?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 21:37","pubTimestamp":1744724238,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时37分，Editas Medicine, Inc.股票出现波动，股价大幅拉升5.21%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Mural Oncology Plc、Skye Bioscience, Inc.、Verve Therapeutics, Inc.涨幅较大，Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为429.43%、204.56%、81.24%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Mural Oncology Plc、Skye Bioscience, Inc.，振幅分别为80.08%、47.57%、39.69%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415213718aa2c6fa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415213718aa2c6fa9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","EDIT"],"gpt_icon":0},{"id":"2527719440","title":"Editas Medicine, Inc.盘中异动 大幅下挫5.23%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527719440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527719440?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 23:18","pubTimestamp":1744643880,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日23时18分，Editas Medicine, Inc.股票出现异动，股价大幅跳水5.23%。截至发稿，该股报1.23美元/股，成交量54.198万股，换手率0.65%，振幅6.92%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为2.23%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414231801aa2c6eb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414231801aa2c6eb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","EDIT"],"gpt_icon":0},{"id":"2527191291","title":"Sangamo Therapeutics, Inc.盘中异动 股价大涨5.01%报0.755美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527191291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527191291?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 23:09","pubTimestamp":1744643372,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日23时09分，Sangamo Therapeutics, Inc.股票出现异动，股价急速拉升5.01%。截至发稿，该股报0.755美元/股，成交量303.195万股，换手率1.35%，振幅4.06%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.28%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041423093294d51bcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041423093294d51bcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4556","LENZ","SGMO"],"gpt_icon":0},{"id":"2527419537","title":"蓝鸟生物盘中异动 早盘股价大跌5.63%报4.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527419537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527419537?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 22:39","pubTimestamp":1744641562,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日22时39分，蓝鸟生物股票出现波动，股价急速跳水5.63%。截至发稿，该股报4.86美元/股，成交量2.3232万股，换手率0.24%，振幅4.08%。最近的财报数据显示，该股实现营业收入83.81百万美元，净利润-2.41亿美元，每股收益-24.84美元，毛利-65.92百万美元，市盈率-0.20倍。机构评级方面，在所有5家参与评级的机构中，20%的券商给予买入建议，80%的券商给予持有建议，无券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中，整体涨幅为1.94%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414223922a4589b74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414223922a4589b74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLUE","BK4556","BK4578","BK4139"],"gpt_icon":0},{"id":"2527164885","title":"Beam Therapeutics Inc.盘中异动 快速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527164885","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527164885?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 21:31","pubTimestamp":1744637468,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时31分，Beam Therapeutics Inc.股票出现波动，股价快速拉升5.11%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041421311094d50a29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041421311094d50a29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4556","BK4505","BK4585","BK4588","LENZ","BK4139","BK4007","BEAM","BK4611"],"gpt_icon":0},{"id":"2526612575","title":"蓝鸟生物盘中异动 快速上涨5.78%报4.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526612575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526612575?lang=zh_cn&edition=fundamental","pubTime":"2025-04-12 02:23","pubTimestamp":1744395802,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日02时23分，蓝鸟生物股票出现波动，股价快速拉升5.78%。截至发稿，该股报4.94美元/股，成交量8.2576万股，换手率0.84%，振幅9.22%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为1.50%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为2128.53%、1717.72%、402.13%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.，振幅分别为193.75%、156.27%、77.44%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041202232394d32471&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041202232394d32471&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLUE","BK4578","BK4556","BK4139"],"gpt_icon":0},{"id":"2526695668","title":"Editas Medicine, Inc.盘中异动 股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526695668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526695668?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 22:07","pubTimestamp":1744380472,"startTime":"0","endTime":"0","summary":"北京时间2025年04月11日22时07分，Editas Medicine, Inc.股票出现异动，股价大幅上涨5.41%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为1.08%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.较为活跃，换手率分别为320.32%、247.81%、98.01%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.，振幅分别为187.50%、84.31%、59.40%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411220752aa2c6c7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411220752aa2c6c7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4556","BK4139"],"gpt_icon":0},{"id":"2526369381","title":"Intellia Therapeutics, Inc.盘中异动 急速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526369381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526369381?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 22:07","pubTimestamp":1744380464,"startTime":"0","endTime":"0","summary":"北京时间2025年04月11日22时07分，Intellia Therapeutics, Inc.股票出现异动，股价大幅上涨5.02%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.08%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041122074594d2ff13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041122074594d2ff13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LENZ","LU1861559042.SGD","BK4139","NTLA","BK4007","BK4556","LU1861558580.USD","BK4535","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}]}}